T. Annie T. Fong

SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.

T. Annie T. Fong, Laura K. Shawver, Li Sun et al. · PubMed · 1999 · 1K citations

Novel Synthetic Compound, Chemoprevention Strategy, Pathology +20

SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.

Alexander Laird, Peter Vajkoczy, Laura K. Shawver et al. · PubMed · 2000 · 497 citations

Pathology, Cancer Biology, Tumor Biology +23

The antitumoral effect of endostatin and angiostatin is associated with a down‐regulation of vascular endothelial growth factor expression in tumor cells

Amin Hajitou, Christine Grignet‐Debrus, Laetitia Devy et al. · The FASEB Journal · 2002 · 162 citations

Inhibition of Tumor Growth, Angiogenesis, and Microcirculation by the Novel Flk-1 Inhibitor SU5416 as Assessed by Intravital Multi-fluorescence Videomicroscopy

Peter Vajkoczy, Michael D. Menger, Brigitte Vollmar et al. · Neoplasia · 1999 · 144 citations · Full text

Biomedical Engineering, Glioma, Angiogenesis Blockage +17

Mouse aortic ring assay: A new approach of the molecular genetics of angiogenesis

Véronique Masson, Laetitia Devy, Christine Grignet‐Debrus et al. · Biological Procedures Online · 2002 · 139 citations · Full text

Vascular Disease, Angiogenesis, Natural Sciences +11